Huge news for women battling advanced uterine cancer: a new treatment just got the green light for NHS use and it’s a legit breakthrough. The combo of pembrolizumab (aka Keytruda) with chemo is proven to slow down tumor growth and boost survival rates—by 26%! Around 2,100 women a year could benefit from this, and it’s being fast-tracked so more patients can get it ASAP. This is real hope for better outcomes and more time with loved ones. #Health #BodyHealth #CancerBreakthrough